Literature DB >> 33998470

The COVID-19 era: Ethics in times of crisis.

F-M Gamboa-Antiñolo1.   

Abstract

Entities:  

Year:  2021        PMID: 33998470      PMCID: PMC7835074          DOI: 10.1016/j.rceng.2020.10.001

Source DB:  PubMed          Journal:  Rev Clin Esp (Barc)        ISSN: 2254-8874


× No keyword cloud information.
Dear Director, I would like to present a brief reflection on the conflict of values that has arisen in clinical care and public health in the COVID-19 pandemic. Spain, like other nations, has been overwhelmed by the COVID-19 pandemic. It has placed a massive burden on the health system, leading to a mismatch between the population’s needs and the availability of clinical care and advanced life support. This situation has forced us to adopt common criteria for the allocation of resources so that serious inequities in care do not emerge. Any criteria or protocol adopted to ration scarce resources must never be applied mechanically or automatically: every human being has the right to personal consideration. However, this does not preclude us from trying to establish general prioritization criteria that must then be applied on an individual basis. Triage in situations of scarcity is not extraordinary in clinical practice; in fact, it is common in organ transplantation and even in routine clinical care in many institutions. To ensure that the ethical principles of fairness and the greatest good for the greatest number of patients are respected, triage criteria should be as objective as possible. These clinical criteria attempt to determine which patients have both a more favorable prognosis (greater chances of survival and benefit derived from treatment) and a shorter a priori duration of expected ICU admission. The issue of age often comes up when determining which criteria to consider. Although older adults are a higher-risk population, age cannot be the sole factor behind the adoption of a behavior, since any decision must depend on the general clinical condition of the patient. However, on the one hand, if we do not take age into account, we too often provide care that is expensive and ineffective. On the other hand, if we make age the sole criterion for making decisions, we are in effect taking a giant step toward openly valuing some lives over others, an approach that challenges the basic principles of medicine. It is true that with advanced age, there is less physiological reserve and lower expectations of complete recovery, but comorbidity, frailty, and clinical complexity better define the limits of adequate treatment than age alone. Furthermore, decision-making must take into account patients’ opinions about their expectations and choices. In regard to properly assigning mechanical ventilation, the criteria should be the same as in normal medical practice. Mechanical ventilation is an intensive treatment that must be indicated according to the objectives set for the intervention and depending on the patient’s medical condition, the evolution of the disease to date, the treatment options, and the prognosis. Although the chances of survival may be low, treatment should continue unless deemed ineffective or at the request of a patient or their surrogate. Once patients have already received mechanical ventilation, the decision to withdraw it is especially difficult. New York State guidelines reject old age as a ranking criterion because it discriminates against older people. Furthermore, age already indirectly influences any criteria that assess an individual's overall health (given that the likelihood of having chronic medical conditions increases with age) and there are many cases in which an older person might have a better clinical outlook than a younger person. Only when all available clinical factors have been examined and the probability of mortality among the patient group has been determined to be equal can age be used as a deciding factor in selecting a patient for ventilator therapy. An ethically sound framework for healthcare during public health emergencies must balance the duty of patient-centered care with the public-centered duties of promoting equality and equity for all in the distribution of risks and benefits in society. It is essential to respect the dignity of each patient. Medical treatment must be proportional to the patient's condition and basic factors (chronic diseases, risk factors, and others) that must be included as part of the analysis of each patient’s possibility of recovery. The choice to set limits on access to treatment is not a discretionary decision, but a necessary response to the overwhelming effects of a pandemic. The difficulty lies in how to do it ethically and consistently, rather than basing decisions on each individual institution’s approach or a physician's intuition in the heat of the moment. Proposals for resource allocation in pandemics concur on four core values: maximizing the benefits of scarce resources, treating people equally, promoting and rewarding instrumental value, and prioritizing the most disadvantaged; no single value is enough on its own. Fair allocation requires a multivalue ethical framework that can be adapted according to the resource and context. This highlights the need for fair and consistent allocation procedures which must be transparent and reflect the guidelines for prioritization that ensure that individual physicians are not faced with the terrible task of making decisions on the fly.2, 10 Overemphasis on resource reallocation without sufficient evidence could have unintended negative consequences for vulnerable populations. In the race to save lives, many governments focused on increasing capacity in acute care hospitals, while subacute care facilities, which often house older adults and people with disabilities, were largely overlooked. As a result, vulnerable groups were not adequately protected. Nursing homes have become hotspots for transmission of and death due to COVID-19. In times of crisis, it is necessary to develop a code of ethics that is capable of encompassing the values of people and the society they live in as well as the uncertainty that disease always entails. A review of the ethics of proper care is needed.

Funding sources

This research did not receive any funding from agencies in the public, commercial, or not-for-profit sectors.
  9 in total

1.  [Limiting therapeutic effort: is withholding or withdrawal of life-sustaining treatment the same?].

Authors:  Fernando Gamboa Antiñolo
Journal:  Med Clin (Barc)       Date:  2009-05-22       Impact factor: 1.725

2.  Comorbidity, clinical complexity and palliative care.

Authors:  Fernando-Miguel Gamboa-Antiñolo
Journal:  Intern Emerg Med       Date:  2020-04-01       Impact factor: 3.397

3.  Age, Complexity, and Crisis - A Prescription for Progress in Pandemic.

Authors:  Louise Aronson
Journal:  N Engl J Med       Date:  2020-04-07       Impact factor: 91.245

4.  Fair Allocation of Scarce Medical Resources in the Time of Covid-19.

Authors:  Ezekiel J Emanuel; Govind Persad; Ross Upshur; Beatriz Thome; Michael Parker; Aaron Glickman; Cathy Zhang; Connor Boyle; Maxwell Smith; James P Phillips
Journal:  N Engl J Med       Date:  2020-03-23       Impact factor: 91.245

5.  The Toughest Triage - Allocating Ventilators in a Pandemic.

Authors:  Robert D Truog; Christine Mitchell; George Q Daley
Journal:  N Engl J Med       Date:  2020-03-23       Impact factor: 91.245

6.  Ethics of reallocating ventilators in the covid-19 pandemic.

Authors:  Andrew Peterson; Emily A Largent; Jason Karlawish
Journal:  BMJ       Date:  2020-05-12

Review 7.  [Covid-19 pandemic. Mechanical ventilation in geriatric patients - an ethical dilemma?]

Authors:  Joachim Zeeh; Kristin Memm; Hans-Jürgen Heppner; Anja Kwetkat
Journal:  MMW Fortschr Med       Date:  2020-05

8.  Triage during the COVID-19 epidemic in Spain: better and worse ethical arguments.

Authors:  Benjamin Herreros; Pablo Gella; Diego Real de Asua
Journal:  J Med Ethics       Date:  2020-05-18       Impact factor: 2.903

9.  COVID-19 in Italy: Ageism and Decision Making in a Pandemic.

Authors:  Matteo Cesari; Marco Proietti
Journal:  J Am Med Dir Assoc       Date:  2020-04-01       Impact factor: 4.669

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.